Palliative 5-fluorouracil-based chemotherapy for advanced colorectal cancer in the elderly: Results of a 10-year experience

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 25, Issue 2, 2002, Pages 126-130

  Magné, Nicholas ^a   François, Eric ^a   Broisin, Laure ^a   Guardiola, Emmanuel ^a   Ramaïoli, Alain ^a   Ferrero, Jean Marc ^a   Namer, Moïse ^a  

^a CENTRE ANTOINE LACASSAGNE   (France)

Author keywords

Advanced colorectal cancer; Chemotherapy; Elderly patients; Quality of life; Toxicity

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADVANCED CANCER; AGED; ANEMIA; ARTICLE; ASTHENIA; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; COLON CANCER; COLORECTAL CANCER; DIARRHEA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; NEUTROPENIA; RECTUM CANCER; STOMATITIS; THROMBOCYTOPENIA;

AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; COLORECTAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; PALLIATIVE CARE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0036220622     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200204000-00005     Document Type: Article

References (18)

1. Colorectal cancer
2. Colorectal cancer
3. Colon cancer in the elderly: Evidence for major improvements in health care and survival
4. Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: Results of a randomized multicenter trial
5. A prospective randomised comparison of continuous infusion fluorouracil with a conventional bolus schedule in metastatic colorectal carcinoma
6. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: A French Intergroup Study
7. Bi-monthly CPTII with leucovorin and 5-fluorouracil in pretreated metastatic colorectal cancer (FOLFIRI)
8. Oxaliplatin (L-OHP) as first-line chemotherapy in metastatic colorectal cancer patients: Preliminary activity/toxicity report
9. Bimonthly 5-fluorouracil in elderly patients with metastatic colorectal cancer. Study of 50 patients
10. Advanced colorectal cancer in the elderly: Results of consecutive trials with 5-fluorouracil-based chemotherapy
11. Adjuvant or palliative chemotherapy for colorectal cancer in patients 70 years or older
12. Managing the side effects of chemotherapy for colorectal cancer
13. Measuring quality of life: Impact of chemotherapy for advanced colorectal cancer. Experience from two recent large phase III trials
14. The importance of stabilization as an endpoint in the treatment of metastatic colorectal carcinoma: Recent quality of life studies
15. Factors influencing quality of life in cancer patients: Anemia and fatigue
16. Adjuvant chemotherapy for colorectal cancer in the elderly: Population-based experience
17. An ongoing phase II study of Tomudex (raltitrexed) in elderly patients with advanced colorectal cancer: An assessment of tolerability and clinical benefit